// App-Quantinova.ai

: The effect of a structured exercise intervention on CTCs and platelet cloaking in patients with metastatic prostate cancer.

Researchers

Presenter

  • Lauren Brady

Principal Investigators

  • Grainne Sheill

  • Anne-Marie Baird

  • Emer M. Guinan

  • Bryan Stanfill

  • Tatjana Vlajnic

  • Orla Casey

  • John Patrick Greene

  • Emma Allott

  • Juliette M. Hussey

  • Fidelma Cahill

  • Mieke Van Hemelrijck

  • Nicola Peat

  • Sarah Maria Rudman

  • Lorelei Mucci

  • Orla Sheils

  • O'Leary John

  • Ray McDermott

  • Stephen P. Finn

Medical Centers

  • Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland

  • Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin,Department of Histopathology, Cork University Hospital, Wilton, Cork, Cork, Ireland

  • University College Dublin, Dublin 4, Ireland

  • Pacific Northwest National Laboratory, Richland, WA

  • Institute for Pathology, University Hospital Basel, Basel, Switzerland

  • Cancer Trials Ireland, Dublin, Ireland

  • Adelaide and Meath Hospital, Dublin, Ireland

  • Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, 8 Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Northern Ireland, Belfast, United Kingdom

  • Trinity College Dublin, School of Medicine, Dublin, Ireland

  • Kings College London, Division of Cancer Studies, Cancer Epidemiology Group, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Harvard School of Public Health, Boston, MA

  • Department of Histopathology, St. James's Hospital, Dublin, Ireland

  • Department of Haematology, AMNCH, Dublin, Ireland

  • St. James's Hospital and Trinity College Dublin, Cancer Molecular Diagnostics, Dublin, Ireland

Locations

  • Ireland

  • United States

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Prostate cancer

  • Acquired pure red cell aplasia

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • NA

Study Id's

  • NCT02453139

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved